Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis. (Q46343336)
Jump to navigation
Jump to search
scientific article published in October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis. |
scientific article published in October 2008 |
Statements
Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis (English)
Hao-Hueng Chang
Chih-Chiang Wang
Chi-Yuan Hong
1 October 2008
1 reference
1 reference
1 reference